Reforming the oversight of multi-site clinical research: A review of two possible solutions

Accountability in Research

Volumn 13, Issue 1, 2006, Pages 11-24

  Nowak, Kristin S ^a   Bankert, Elizabeth A ^a   Nelson, Robert M ^b,c  

^a DARTMOUTH COLLEGE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Clinical research; Institutional review board; Multi site research; Pharmaceutical research; Regional ethics organization

Indexed keywords

ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; ETHICS; HUMAN; INTERNET; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PROFESSIONAL STANDARD; STANDARD; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

CLINICAL TRIALS; ETHICAL REVIEW; ETHICS COMMITTEES, RESEARCH; HUMANS; INTERNET; MULTICENTER STUDIES; UNITED STATES;

EID: 33746521885     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989620600588845     Document Type: Review

References (30)

1. Alberti, K. G. M. M. (2000). Multicentre research ethics committees: has the cure been worse than the disease?, BMJ, 320(7243): 1157-1158.
2. Anonymous. (2001). Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. In Official J European Comm. L 121: 34-44.
3. Ashcroft, R. E., Newson, A. J., and Benn, P. M. (2005). Reforming research ethics committees, BMJ, 331(7517): 587-588.
4. Boyce, M. (2002). Observational study of 353 applications to London multicen-tre research ethics committee 1997-2000, BMJ, 325(7372): 1081.
5. Brown, J. G. (1998). Institutional Review Boards: A Time for Reform. Department of Health and Human Services (ed.). Washington, DC: Office of the Inspector General.
6. Christian, M. C., Goldberg, J. L., Killen, J., Abrams, J. S., McCabe, M. S., Maver, J. K., and Wittes, R. E. (2002). A central institutional review board for multi-institutional trials, N Engl J Med, 346(18): 1405-1408.
7. Clinical Data Interchange Standards Consortium. (2004). Standard Protocol Elements for Regulated Clinical Trials: Comprehensive Element List. Accessed on July 25, 2005. Available at http://www.cdisc.org/standards/ProtocolElements_FullList1-0-0.pdf.
8. Dziak, K., et al. (2005). Variations among Institutional Review Board reviews in a multisite health services research study, Health Services Research, 40(1): 279-290.
9. Emanuel, E. J., Wood, E., Fleischman, A., Bowen, A., Getz, K. A., Grady, C., Levine, C., Hammerschmidt, D. E., Faden, R., Eckenwiler, L., Muse, C. T., and Sugarman, J. (2004). Oversight of human participants research: identifying problems to evaluate reform proposals, Ann Internal Med, 141(4): 282-291.
10. Federman, D. D., Hanna, K. E., and Rodriguez, L. L. (eds.). (2002). Responsible Research: A Systems Approach to Protecting Research Participants. Washington, DC: The National Academies Press.
11. Food and Drug Administration. (1997). International Conference on Harmoni-sation; Good Clinical Practice: Consolidated Guideline; Availability, Federal Register, 62(90): 25692-25709.
12. Food and Drug Administration. (2001). International Conference on Harmoni-sation; Choice of Control Group and Related Issues in Clinical Trials; Availability, Federal Register, 66(93): 24390-24391.
13. Glasziou, P., and Chalmers, I. (2004). Ethics review roulette: what can we learn?, BMJ, 328(7432): 121-122.
14. Gold, J. L., and Dewa, C. S. (2005). Institutional review boards and multisite studies in health services research: is there a better way? Health Services Research, 40(1): 291-307.
15. Hearnshaw, H. (2004). Comparison of requirements of research ethics committees in 11 European countries for a non-invasive interventional study, BMJ, 328(7432): 140-141.
16. Human Research Subject Protections Act of 2002. H.R.4697. Sponsored by Representative Diana DeGette. U.S. House of Representatives. 107th Congress.
17. Kelch, R. P. (2002). Maintaining the public trust in clinical research, N Engl J Med, 346(4): 285-287.
18. Koski, G., et al. (2005). Cooperative Research Ethics Review Boards: A Win-Win Solution? IRB: Ethics and Human Research, 27(3): 1-7.
19. Lewis, J. C., Tomkins, S., and Sampson, J. R. (2001). Ethical approval for research involving geographically dispersed subjects: unsuitability of the UK MREC/LREC system and relevance to uncommon genetic disorders, J Med Ethics, 27(5): 347-351.
20. Lux, A. L., Edwards, S. W., and Osborne, J. P. (2000). Responses of local research ethics committees to a study with approval from a multicentre research ethics committee, BMJ, 320(7243): 1182-1183.
21. McWilliams, R., Hoover-Fong, J., Hamosh, A., Beck, S., Beaty, T., and Cutting, G. (2003). Problematic variation in local institutional review of a multicenter genetic epidemiology study, JAMA, 290(3): 360-366.
22. Office for Human Research Protections. (2005). Institutional Review Board (IRB)/ Independent Ethics Committee (IEC) Authorization Agreement. Accessed on July 26, 2005. Available at http://www.hhs.gov/ohrp/humansubjects/assurance/iprotsup.rtf.
23. Public Responsibility in Medicine and Research. Certification. Accessed on October 15, 2005. Available at http://www.primr.org/certification/overview.html
24. Research Revitalization Act of 2002. Senate Bill 3060. Sponsored by Senator Edward M. Kennedy. 107th Congress.
25. Stair, T. O., Reed, C. R., Radeos, M. S., Koski, G., and Camargo, C. A. (2001). Variation in institutional review board responses to a standard protocol for a multicenter clinical trial, Academic Emergency Medicine, 8(6): 636-641.
26. The Association for the Accreditation of Human Research Protection Programs, Inc. Accessed on October 15, 2005. Available at http://www.aahrpp.org/www.aspx.
27. Tully, J., et al. (2000). The new system of review by multicentre research ethics committees: prospective study. [see comment], BMJ, 320(7243): 1179-1182.
28. Wagner, T. H., et al. (2003). The cost of operating institutional review boards (IRBs), Academic Medicine, 78(6): 638-644.
29. Wagner, T. H., Cruz, A. M., and Chadwick, G. L. (2004). Economies of scale in institutional review boards, Medical Care, 42(8): 817-823.
30. Wood, A., Grady, C., and Emanuel, E. J. (2004). Regional ethics organizations for protection of human research participants, Nature Medicine, 10(12): 1283-1288.